Need help finding what you are looking for?
Contact Us
PUBLISHER: BCC Research | PRODUCT CODE: 1630508
PUBLISHER: BCC Research | PRODUCT CODE: 1630508
Biomarkers: Technologies and Global Markets
PUBLISHED:
PAGES: 165 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
The global market for biomarkers was valued at $63.7 billion in 2023. This market is expected to grow from $70.5 billion in 2024 to $130.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 13.1% from 2024 through 2029.
The global market for biomarker consumables is expected to grow from $40.8 billion in 2024 to $74.0 billion by the end of 2029, at a CAGR of 12.7% from 2024 through 2029.
The global market for biomarker instruments is expected to grow from $17.5 billion in 2024 to $33.9 billion by the end of 2029, at a CAGR of 14.1% from 2024 through 2029.
Report Scope:
The scope of this report on the global market for biomarker technologies encompasses an analysis of the current landscape, including market size, growth trends and segmentation by product type, technology, therapeutic area and end user. The report breaks down the market into several product categories: instruments, consumables (such as reagents, kits and panels), services and software. It also segments the market by technology: genomics, proteomics, metabolomics, imaging and bioinformatics. It also examines the biomarker market across the therapeutic areas of cancer; cardiovascular, metabolic, infectious and neurodegenerative diseases; and autoimmune disorders. The end-user segments are academic institutions, pharmaceutical and biotechnology companies, clinical research organizations, hospitals and diagnostic centers.
By region, the analysis encompasses North America, Europe, Asia-Pacific, and the Rest of the World (RoW). The report also includes profiles of leading companies and highlights industry trends, major products, mergers and acquisitions, and other collaborations or partnerships.
Report Includes:
- 34 data tables and 62 additional tables
- An up-to-date overview of the global markets and technologies for biomarkers
- Analysis of the global market trends, with data from 2021-2023, estimates for 2024, and projections of compound annual growth rates (CAGRs) through 2029
- Evaluation of the size and revenue growth prospects, accompanied by a market share analysis by product type, technology, therapeutic area, end user, and region
- Assessment of market dynamics such as drivers, restraints and opportunities
- Coverage of major types of biomarkers and their use in clinical trial assessment, drug discovery and development, and therapeutics
- Review of patents issued for biomarker technologies and deep dive of patent data by year, technology type, application, company, assignee and applicant country
- A discussion on ESG challenges and practices in the industry
- Assessment of the vendor landscape, including the market shares of key companies, their product portfolios and financial overviews
- Information on recent mergers, acquisitions, expansions, collaborations, investments, divestments, product launches, and other strategic developments
- Profiles of the leading companies, including F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Illumina Inc., Bio-Rad Laboratories Inc., and Agilent Technologies Inc.
Product Code: BIO061G
Table of Contents
Chapter 1 Executive Summary
- Market Outlook
- Scope of Report
- Market Summary
Chapter 2 Market Overview
- Overview
- Classification of Biomarkers
- Examples of Biomarkers
- Susceptibility/Risk Biomarkers
- Diagnostic Biomarkers
- Monitoring Biomarkers
- Prognostic Biomarkers
- Predictive Biomarkers
- Pharmacodynamic (Response) Biomarkers
- Safety Biomarkers
- Surrogate Biomarkers/Endpoints
- Discovery, Verification and Validation
- Biomarker Qualification
- Applications of Biomarkers
- Diagnostics, Therapeutics and Disease Monitoring
- Drug Discovery and Development
- Clinical Trials
Chapter 3 Market Dynamics
- Overview
- Market Drivers
- Rising Incidence of Diseases
- Advances in Omics and Imaging Technologies
- Market Restraints
- High Development Costs
- Requirement for Skilled Labor
- Market Opportunities
- Emerging Markets
- Personalized Medicine
Chapter 4 Emerging Technologies and Developments
- Overview
- Emerging Technologies
- Genomics
- Proteomics
- Metabolomics
- Imaging
- Bioinformatics
- Clinical Trials
- Clinical Trial Analysis, by Therapeutic Area
- Clinical Trial Analysis, by Study Status
- Clinical Trial Analysis, by Study Type
- Patent Analysis
Chapter 5 Market Segmentation Analysis
- Market Trends
- Segmentation Breakdown
- Biomarkers: Global Markets
- Market Analysis by Product Type
- Consumables
- Instruments
- Services
- Software
- Market Analysis by Technology
- Proteomics
- Genomics
- Imaging
- Bioinformatics
- Metabolomics
- Market Analysis by Therapeutic Area
- Cancer
- Cardiovascular and Metabolic Diseases
- Neurodegenerative Diseases
- Infectious Diseases
- Autoimmune Diseases
- Other Diseases
- Market Analysis by End User
- Hospitals and Diagnostic Labs
- Academic and Research Institutes
- Pharmaceutical and Biotech Companies
- Contract Research Organizations
- Geographic Breakdown
- Market Analysis by Region
- North America
- Europe
- Asia-Pacific
- Rest of the World
Chapter 6 Competitive Intelligence
- Ranking of Companies in the Biomarker Industry
Chapter 7 Sustainability in Biomarkers Technologies and Global Markets: An ESG Perspective
- Sustainability in the Biomarker Market
- ESG Risks and Ratings: Understanding the Data
- BCC Research Viewpoint
Chapter 8 Appendix
- Methodology
- Sources
- Abbreviations
- Company Profiles
- ABBOTT
- AGILENT TECHNOLOGIES INC.
- BAYER AG
- BD
- BIO-RAD LABORATORIES INC.
- BRUKER
- DANAHER CORP.
- F. HOFFMANN-LA ROCHE LTD.
- FUJIFILM HOLDINGS CORP.
- GE HEALTHCARE
- ILLUMINA INC.
- JEOL LTD.
- KONINKLIJKE PHILIPS N.V.
- PROMEGA CORP.
- QIAGEN
- REVVITY
- SHIMADZU CORP.
- SIEMENS HEALTHINEERS AG
- THERMO FISHER SCIENTIFIC INC.
Product Code: BIO061G
List of Tables
- Summary Table A : Global Market for Biomarkers, by Product Type, Through 2029
- Summary Table B : Global Market for Biomarkers, by Region, Through 2029
- Table 1 : Categories of Biomarkers
- Table 2 : Examples of Biomarkers
- Table 3 : Clinical Trials in Biomarkers, by Therapeutic Area, 2021-2024*
- Table 4 : Clinical Trials in Biomarkers, by Study Status, 2021-2024*
- Table 5 : Clinical Trials in Biomarkers, by Type of Study, 2021-2024*
- Table 6 : Patents Issued for Biomarkers, 2021-2024*
- Table 7 : Patents Issued for Biomarkers, by Applicant, 2021-2024*
- Table 8 : Global Market for Biomarkers, Through 2029
- Table 9 : Global Market for Biomarkers, by Product Type, Through 2029
- Table 10 : Global Market for Biomarkers, by Technology, Through 2029
- Table 11 : Global Market for Biomarkers, by Therapeutic Area, Through 2029
- Table 12 : Global Market for Biomarkers, by End User, Through 2029
- Table 13 : Global Market for Biomarkers, by Region, Through 2029
- Table 14 : North American Market for Biomarkers, by Country, Through 2029
- Table 15 : European Market for Biomarkers, by Country, Through 2029
- Table 16 : Asia-Pacific Market for Biomarkers, by Country, Through 2029
- Table 17 : RoW Market for Biomarkers, by Sub-region, Through 2029
- Table 18 : Market Rankings of Leading Companies in the Biomarker Industry, 2023
- Table 19 : ESG Rankings for Major Biomarker Companies, 2024*
- Table 20 : Information Sources in This Report
- Table 21 : Abbreviations Used in This Report
- Table 22 : Abbott: Company Snapshot
- Table 23 : Abbott: Financial Performance, FY 2022 and 2023
- Table 24 : Abbott: Product Portfolio
- Table 25 : Abbott: News/Key Developments, 2023-2024
- Table 26 : Agilent Technologies Inc.: Company Snapshot
- Table 27 : Agilent Technologies Inc.: Financial Performance, FY 2022 and 2023
- Table 28 : Agilent Technologies Inc.: Product Portfolio
- Table 29 : Agilent Technologies Inc.: News/Key Developments, 2023-2024
- Table 30 : Bayer AG: Company Snapshot
- Table 31 : Bayer AG: Financial Performance, FY 2022 and 2023
- Table 32 : Bayer AG: Product Portfolio
- Table 33 : Bayer AG: News/Key Developments, 2022-2024
- Table 34 : BD: Company Snapshot
- Table 35 : BD: Financial Performance, FY 2022 and 2023
- Table 36 : BD: Product Portfolio
- Table 37 : BD: News/Key Developments, 2024
- Table 38 : Bio-Rad Laboratories Inc.: Company Snapshot
- Table 39 : Bio-Rad Laboratories Inc.: Financial Performance, FY 2022 and 2023
- Table 40 : Bio-Rad Laboratories Inc.: Product Portfolio
- Table 41 : Bio-Rad Laboratories Inc.: News/Key Developments, 2024
- Table 42 : Bruker: Company Snapshot
- Table 43 : Bruker: Financial Performance, FY 2022 and 2023
- Table 44 : Bruker: Product Portfolio
- Table 45 : Bruker: News/Key Developments, 2023
- Table 46 : Danaher Corp.: Company Snapshot
- Table 47 : Danaher Corp.: Financial Performance, FY 2022 and 2023
- Table 48 : Danaher Corp.: Product Portfolio
- Table 49 : Danaher Corp.: News/Key Developments, 2022-2024
- Table 50 : F. Hoffmann-La Roche Ltd.: Company Snapshot
- Table 51 : F. Hoffmann-La Roche Ltd.: Financial Performance, FY 2022 and 2023
- Table 52 : F. Hoffmann-La Roche Ltd.: Product Portfolio
- Table 53 : F. Hoffmann-La Roche Ltd.: News/Key Developments, 2023
- Table 54 : Fujifilm Holdings Corp.: Company Snapshot
- Table 55 : Fujifilm Holdings Corp.: Financial Performance, FY 2022 and 2023
- Table 56 : Fujifilm Holdings Corp.: Product Portfolio
- Table 57 : GE Healthcare: Company Snapshot
- Table 58 : GE Healthcare: Financial Performance, FY 2022 and 2023
- Table 59 : GE Healthcare: Product Portfolio
- Table 60 : GE Healthcare: News/Key Developments, 2024
- Table 61 : Illumina Inc.: Company Snapshot
- Table 62 : Illumina: Financial Performance, FY 2022 and 2023
- Table 63 : Illumina: Product Portfolio
- Table 64 : Illumina Inc.: News/Key Developments, 2024
- Table 65 : JEOL Ltd.: Company Snapshot
- Table 66 : JEOL Ltd.: Financial Performance, FY 2022 and 2023
- Table 67 : JEOL Ltd.: Product Portfolio
- Table 68 : JEOL Ltd.: News/Key Developments, 2023
- Table 69 : Koninklijke Philips N.V.: Company Snapshot
- Table 70 : Koninklijke Philips N.V.: Financial Performance, FY 2022 and 2023
- Table 71 : Koninklijke Philips N.V.: Product Portfolio
- Table 72 : Koninklijke Philips N.V.: News/Key Developments, 2022 and 2023
- Table 73 : Promega Corp.: Company Snapshot
- Table 74 : Promega Corp.: Product Portfolio
- Table 75 : Promega Corp.: News/Key Developments, 2023 and 2024
- Table 76 : Qiagen: Company Snapshot
- Table 77 : Qiagen: Financial Performance, FY 2022 and 2023
- Table 78 : Qiagen: Product Portfolio
- Table 79 : Qiagen: News/Key Developments, 2023
- Table 80 : Revvity: Company Snapshot
- Table 81 : Revvity: Financial Performance, FY 2022 and 2023
- Table 82 : Revvity: Product Portfolio
- Table 83 : Revvity: News/Key Developments, 2022 and 2023
- Table 84 : Shimadzu Corp.: Company Snapshot
- Table 85 : Shimadzu Corp.: Financial Performance, FY 2022 and 2023
- Table 86 : Shimadzu Corp.: Product Portfolio
- Table 87 : Shimadzu Corp.: News/Key Developments, 2023
- Table 88 : Siemens Healthineers AG: Company Snapshot
- Table 89 : Siemens Healthineers AG: Financial Performance, FY 2022 and 2023
- Table 90 : Siemens Healthineers AG: Product Portfolio
- Table 91 : Siemens Healthineers AG: News/Key Developments, 2024
- Table 92 : Thermo Fisher Scientific Inc.: Company Snapshot
- Table 93 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2022 and 2023
- Table 94 : Thermo Fisher Scientific Inc.: Product Portfolio
- Table 95 : Thermo Fisher Scientific Inc.: News/Key Developments, 2023 and 2024
List of Figures
- Summary Figure A : Global Market for Biomarkers, by Product Type, 2021-2029
- Summary Figure B : Global Market for Biomarkers, by Product Type, 2021-2029
- Figure 1 : Snapshot of the Market Dynamics of Biomarkers
- Figure 2 : Share of Global Market for Biomarkers, by Product Type, 2023
- Figure 3 : Share of Global Market for Biomarkers, by Technology, 2023
- Figure 4 : Share of Global Market for Biomarkers, by Therapeutic Area, 2023
- Figure 5 : Share of Global Market for Biomarkers, by End User, 2023
- Figure 6 : Share of Global Market for Biomarkers, by Region, 2023
- Figure 7 : Share of North American Market for Biomarkers, by Country, 2023
- Figure 8 : Share of European Market for Biomarkers, by Country, 2023
- Figure 9 : Share of Asia-Pacific Market for Biomarkers, by Country, 2023
- Figure 10 : Share of RoW Market for Biomarkers, by Sub-region, 2023
- Figure 11 : Abbott: Revenue Share, by Business Unit, FY 2023
- Figure 12 : Abbott: Revenue Share, by Country/Region, FY 2023
- Figure 13 : Agilent Technologies Inc.: Revenue Share, by Business Unit, FY 2023
- Figure 14 : Agilent Technologies Inc.: Revenue Share, by Country/Region, FY 2023
- Figure 15 : Bayer AG: Revenue Share, by Business Unit, FY 2023
- Figure 16 : Bayer AG: Revenue Share, by Country/Region, FY 2023
- Figure 17 : BD: Revenue Share, by Business Unit, FY 2023
- Figure 18 : BD: Revenue Share, by Country/Region, FY 2023
- Figure 19 : Bio-Rad Laboratories Inc.: Revenue Share, by Business Unit, FY 2023
- Figure 20 : Bio-Rad Laboratories Inc.: Revenue Share, by Country/Region, FY 2023
- Figure 21 : Bruker: Revenue Share, by Business Unit, FY 2023
- Figure 22 : Bruker: Revenue Share, by Country/Region, FY 2023
- Figure 23 : Danaher Corp.: Revenue Share, by Business Unit, FY 2023
- Figure 24 : Danaher Corp.: Revenue Share, by Country/Region, FY 2023
- Figure 25 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Business Unit, FY 2023
- Figure 26 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Country/Region, FY 2023
- Figure 27 : Fujifilm Holdings Corp.: Revenue Share, by Business Unit, FY 2023
- Figure 28 : Fujifilm Holdings Corp.: Revenue Share, by Country/Region, FY 2023
- Figure 29 : GE Healthcare: Revenue Share, by Business Unit, FY 2023
- Figure 30 : GE Healthcare: Revenue Share, by Country/Region, FY 2023
- Figure 31 : Illumina: Revenue Share, by Business Unit, FY 2023
- Figure 32 : Illumina: Revenue Share, by Country/Region, FY 2023
- Figure 33 : JEOL Ltd.: Revenue Share, by Business Unit, FY 2023
- Figure 34 : JEOL Ltd.: Revenue Share, by Country/Region, FY 2023
- Figure 35 : Koninklijke Philips N.V.: Revenue Share, by Business Unit, FY 2023
- Figure 36 : Koninklijke Philips N.V.: Revenue Share, by Country/Region, FY 2023
- Figure 37 : QIAGEN: Revenue Share, by Business Unit, FY 2023
- Figure 38 : Qiagen: Revenue Share, by Country/Region, FY 2023
- Figure 39 : Revvity: Revenue Share, by Business Unit, FY 2023
- Figure 40 : Revvity: Revenue Share, by Country/Region, FY 2023
- Figure 41 : Shimadzu Corp.: Revenue Share, by Business Unit, FY 2023
- Figure 42 : Shimadzu Corp.: Revenue Share, by Country/Region, FY 2023
- Figure 43 : Siemens Healthineers AG: Revenue Share, by Business Unit, FY 2023
- Figure 44 : Siemens Healthineers AG: Revenue Share, by Country/Region, FY 2023
- Figure 45 : Thermo Fisher Scientific Inc.: Revenue Share, by Business Unit, 2023
- Figure 46 : Thermo Fisher Scientific Inc.: Revenue Share, by Country/Region, 2023
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.